课题基金 / 基金详情

项目摘要

项目成果

VARMAN T SAMUEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): During the tenure of this K23 Award, Dr. Samuel will pursue the mechanism of fat-induced hepatic insulin resistance. He will develop the skills for in vivo human metabolic studies through didactic classes and practical experience. Under the guidance of expert mentors, he will receive training in NMR spectroscopy and GC/MS metholdogy. With these techniques, he will explore the relationship between hepatic fat accumulation, insulin resistance and type 2 diabetes mellitus, conditions that are increasingly common in American. Type 2 diabetes mellitus affects approximately 6% of the population and costs $100 billion dollars annually. Although hepatic insulin resistance is a cardinal feature of this disease, its mechanism is undetermined. There is growing appreciation that many patients with type 2 diabetes mellitus hae hepatic fat accumulation. Given that muscle fat accumulation causes peripheral insulin reisstance, we hypothesize that hepatic fat accumulation leads to hepatic insulin resistance. We predict that hepatic fat accumulation will impair the insulin signaling cascade by limiting the ability of IRS2 to activate PI3 kinase. This will impair the ability of insulin to stimulate glycogen synthesis. We also hypothesize that hepatic fat accumulation will lead to increased gluconeogenesis as a result of increased pyruvate carboxylase activity and increase transcription of PEP-CK. Both are key regulatory enzymes in gluconeogenesis. We will tests these hypotheses, lean subjects consuming a high fat diet. We predict that fat will accumulate within the liver prior to the muscle. With [13C] NMR measures of glycogenolysis, gluconeogenesis and hepatic insulin sensitivity. Through a complementary rat model of fiet induced hepatic steatosis we can examine changes in the signaling cascade, enzyme activity and gene transcription. Using adenoviral transfer of the UCP2 gene into rat livers, we will determine if increased uncoupling prevents diet induced hepatic steatosis and insulin resistance. Finally, with a novel method to directly measure gluconeogenesis, we will determine if hepatic fat accumulation increases hepatic gluconeogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring mitochondrialflux and lipid compartmentation in vivo to develop new therapies for alcoholic liver disease
  • 批准号:
    10620346
  • 项目类别:
  • 资助金额:
    $19.89万
  • 财政年份:
    2022
  • 负责人:
    VARMAN T SAMUEL
  • 依托单位:
Exploring mitochondrialflux and lipid compartmentation in vivo to develop new therapies for alcoholic liver disease
  • 批准号:
    10451071
  • 项目类别:
  • 资助金额:
    $24.08万
  • 财政年份:
    2022
  • 负责人:
    VARMAN T SAMUEL
  • 依托单位:
Cellular Mechanisms for Increased Gluconeogenesis in Type 2 Diabetes
  • 批准号:
    8762400
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    VARMAN T SAMUEL
  • 依托单位:
Cellular Mechanisms for Increased Gluconeogenesis in Type 2 Diabetes
  • 批准号:
    8413409
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    VARMAN T SAMUEL
  • 依托单位:
国内基金
海外基金
猪卵母细胞脂源性代谢物Acetyl-CoA和α-KG调控体细胞核移植表观遗传重编程机制研究
  • 批准号:
    32372884
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    金君学
  • 依托单位:
酮戊二酸调控线粒体代谢稳态抑制Acetyl-CoA胞质运输逆转高脂诱导的细胞衰老研究
  • 批准号:
    82360285
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    31.3万元
  • 批准年份:
    2023
  • 负责人:
    邬真力
  • 依托单位:
PACS2/Acetyl-CoA信号轴调控巨噬细胞脂肪酸代谢介导早期动脉粥样硬化的机制研究
  • 批准号:
    2023JJ30838
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    闾宏伟
  • 依托单位: